Advances in drug delivery to high grade gliomas

Brain Pathol. 2016 Nov;26(6):689-700. doi: 10.1111/bpa.12423. Epub 2016 Aug 24.

Abstract

If cancer is hard to be treated, brain cancer is even more, caused by the inability of many effective drugs given systemically to cross the blood brain and blood tumor barriers and reach adequate concentrations at the tumor sites. Effective delivery of drugs to brain cancer tissues is thus a necessary, albeit not sufficient, condition to effectively target the disease. In order to analyze the current status of research on drug delivery to high grade gliomas (HGG-WHO grades III and IV), the most frequent and aggressive brain cancers, a literature search was conducted in PubMed using the terms: "drug delivery and brain tumor" over the publication year 2015. Currently explored drug delivery techniques for HGG include the convection and permeabilization-enhanced deliveries, drug-releasing depots and Ommaya reservoirs. The efficacy/safety ratio widely varies among these techniques and the success of current efforts to increase this ratio widely varies as well.

Keywords: Ommaya reservoir; blood brain barrier; blood tumor barrier; convection-enhanced delivery; polymeric depot.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Brain Neoplasms / diagnostic imaging*
  • Convection
  • Drug Delivery Systems / methods*
  • Glioma / drug therapy*
  • Humans

Substances

  • Antineoplastic Agents